AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE

AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE was reported 4131 times

AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FUNGAL TEST 8 0.6154
1 CENTRAL NERVOUS SYSTEM MASS 10 0.1053
2 WALL MOTION SCORE INDEX ABNORMAL 10 0.0909
3 PRIMARY CILIARY DYSKINESIA 3 0.0811
4 AIRWAY REMODELLING 10 0.0806
5 PROLONGED EXPIRATION 17 0.0649
6 BLOOD FOLATE DECREASED 44 0.0605
7 ATOPY 14 0.0504
8 PANCREATIC CALCIFICATION 5 0.0385
9 NATURAL KILLER CELL COUNT DECREASED 3 0.0326
10 HAEMORRHAGIC HEPATIC CYST 3 0.0316
11 SPUTUM PURULENT 18 0.0274
12 PRECANCEROUS CONDITION 17 0.0254
13 URTICARIAL VASCULITIS 11 0.0208
14 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 36 0.0176
15 ALLERGY TO VACCINE 5 0.0162
16 DEAFNESS PERMANENT 3 0.0153
17 ASPIRIN-EXACERBATED RESPIRATORY DISEASE 9 0.0146
18 CARDIAC SEPTAL DEFECT 10 0.0139
19 REVERSIBLE AIRWAYS OBSTRUCTION 7 0.0138
20 EOSINOPHILIC MYOCARDITIS 10 0.0137
21 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 6 0.0135
22 BLOOD IMMUNOGLOBULIN E INCREASED 32 0.0132
23 ALLERGY TO PLANTS 6 0.0131
24 BREATHING-RELATED SLEEP DISORDER 3 0.0127
25 CHRONIC SINUSITIS 47 0.0125
26 MEAN PLATELET VOLUME DECREASED 10 0.0119
27 INFUSION SITE SCAR 5 0.0113
28 AMAUROSIS FUGAX 12 0.0111
29 MICROANGIOPATHY 10 0.0106
30 HYPOSMIA 16 0.0106
31 ADMINISTRATION SITE ERYTHEMA 3 0.0105
32 AGITATED DEPRESSION 3 0.0104
33 MITE ALLERGY 6 0.0092
34 PERIPHERAL NERVE LESION 3 0.0091
35 LYMPHOID TISSUE HYPERPLASIA 3 0.0085
36 VOCAL CORD DYSFUNCTION 4 0.0081
37 CARDIAC INFECTION 6 0.0080
38 NASAL DISCHARGE DISCOLOURATION 11 0.0080
39 BONE MARROW INFILTRATION 3 0.0078
40 NASAL SEPTUM PERFORATION 5 0.0077
41 BODY MASS INDEX INCREASED 10 0.0074
42 SKIN SENSITISATION 7 0.0068
43 SPONTANEOUS HAEMATOMA 5 0.0067
44 SINUSITIS BACTERIAL 7 0.0066
45 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 5 0.0065
46 PREMATURE EJACULATION 4 0.0062
47 APRAXIA 9 0.0061
48 INFUSION SITE URTICARIA 4 0.0060
49 PNEUMOTHORAX SPONTANEOUS 4 0.0059
50 NASAL POLYPS 29 0.0059
51 EOSINOPHIL COUNT DECREASED 14 0.0059
52 ALLERGIC SINUSITIS 5 0.0058
53 ALLERGY TO ANIMAL 6 0.0056
54 HYPEREOSINOPHILIC SYNDROME 3 0.0055
55 NASAL DISCOMFORT 43 0.0054
56 CONJUNCTIVITIS ALLERGIC 8 0.0054
57 SINUS ARRHYTHMIA 7 0.0054
58 NASAL OBSTRUCTION 10 0.0053
59 PERFUME SENSITIVITY 3 0.0053
60 UPPER-AIRWAY COUGH SYNDROME 40 0.0049
61 POST PROCEDURAL INFLAMMATION 3 0.0048
62 SPUTUM DISCOLOURED 46 0.0048
63 INFUSION SITE BRUISING 10 0.0046
64 NASAL SEPTUM DEVIATION 9 0.0046
65 FORCED EXPIRATORY VOLUME DECREASED 13 0.0046
66 INFUSION SITE HAEMORRHAGE 15 0.0046
67 CENTRAL SEROUS CHORIORETINOPATHY 3 0.0044
68 RHINALGIA 12 0.0044
69 SINUS OPERATION 10 0.0042
70 MULTIPLE ALLERGIES 32 0.0041
71 SUBCUTANEOUS EMPHYSEMA 4 0.0041
72 OTORRHOEA 7 0.0040
73 INFUSION SITE DISCHARGE 7 0.0040
74 GENITAL HYPOAESTHESIA 4 0.0039
75 RESPIRATORY SYMPTOM 11 0.0039
76 BRONCHIAL DISORDER 6 0.0039
77 SINUS PAIN 9 0.0039
78 NASAL DRYNESS 24 0.0038
79 CROUP INFECTIOUS 3 0.0038
80 INFUSION SITE MASS 4 0.0037
81 VEIN RUPTURE 6 0.0036
82 SEASONAL ALLERGY 49 0.0035
83 GENERALISED ANXIETY DISORDER 5 0.0034
84 BLOOD IMMUNOGLOBULIN G INCREASED 4 0.0033
85 DEVICE INFUSION ISSUE 8 0.0032
86 NASAL PRURITUS 4 0.0032
87 EOSINOPHILIC PNEUMONIA 10 0.0032
88 SOLAR LENTIGO 3 0.0032
89 VENTRICULAR HYPOKINESIA 10 0.0031
90 RHINITIS 25 0.0031
91 ANIMAL SCRATCH 3 0.0031
92 OBSTRUCTIVE AIRWAYS DISORDER 34 0.0031
93 VIITH NERVE PARALYSIS 10 0.0029
94 INFUSION SITE DISCOMFORT 3 0.0029
95 GASTROINTESTINAL VIRAL INFECTION 3 0.0029
96 HYPOPNOEA 10 0.0029
97 THERAPEUTIC PROCEDURE 4 0.0029
98 EMOTIONAL POVERTY 5 0.0029
99 INFUSION SITE PRURITUS 9 0.0028
100 MAST CELL ACTIVATION SYNDROME 4 0.0028
101 NASAL INFLAMMATION 3 0.0028
102 PRE-EXISTING CONDITION IMPROVED 17 0.0027
103 HALO VISION 3 0.0027
104 METABOLIC SURGERY 3 0.0026
105 INFUSION SITE PAIN 34 0.0026
106 PELVIC ABSCESS 3 0.0026
107 CARBON DIOXIDE DECREASED 3 0.0026
108 RESTRICTIVE PULMONARY DISEASE 3 0.0026
109 TONGUE HAEMORRHAGE 3 0.0026
110 INFUSION SITE SWELLING 16 0.0025
111 BLOOD COUNT ABNORMAL 38 0.0025
112 DYSPLASIA 3 0.0025
113 SNEEZING 56 0.0025
114 SENSITIVITY TO WEATHER CHANGE 13 0.0025
115 INFUSION SITE WARMTH 3 0.0024
116 EOSINOPHIL COUNT INCREASED 20 0.0024
117 ASTHMA 267 0.0024
118 SPUTUM INCREASED 5 0.0023
119 RHINITIS ALLERGIC 10 0.0022
120 CYSTITIS NONINFECTIVE 3 0.0022
121 FEAR OF DEATH 5 0.0022
122 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 3 0.0022
123 PNEUMOMEDIASTINUM 4 0.0022
124 ANOSMIA 32 0.0022
125 BODY TEMPERATURE ABNORMAL 4 0.0022
126 AFFECTIVE DISORDER 17 0.0022
127 AURA 4 0.0021
128 TUNNEL VISION 4 0.0021
129 CATAPLEXY 3 0.0021
130 OTITIS MEDIA 7 0.0021
131 NAIL INFECTION 3 0.0021
132 BRONCHIECTASIS 14 0.0021
133 WHEEZING 123 0.0021
134 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 35 0.0021
135 PULMONARY PAIN 6 0.0021
136 BRONCHITIS CHRONIC 5 0.0020
137 COMPLEX REGIONAL PAIN SYNDROME 3 0.0020
138 GLUCOSE TOLERANCE IMPAIRED 12 0.0020
139 HIATUS HERNIA 26 0.0020
140 APHONIA 28 0.0020
141 HYPERPARATHYROIDISM SECONDARY 5 0.0020
142 SINUSITIS 204 0.0020
143 PULMONARY MASS 29 0.0019
144 SUBSTANCE USE 3 0.0019
145 BLOOD BLISTER 6 0.0019
146 ENTHESOPATHY 3 0.0019
147 FOOD INTOLERANCE 7 0.0019
148 EMPHYSEMA 19 0.0019
149 NASAL ULCER 3 0.0019
150 NASAL DISORDER 5 0.0019
151 NASAL CONGESTION 110 0.0019
152 SINUS DISORDER 36 0.0018
153 LUNG CONSOLIDATION 5 0.0018
154 ORAL PRURITUS 4 0.0017
155 ACUTE SINUSITIS 3 0.0017
156 INFUSION SITE INFECTION 4 0.0017
157 PATELLA FRACTURE 4 0.0017
158 TERMINAL INSOMNIA 3 0.0017
159 FOOD ALLERGY 13 0.0017
160 INFUSION SITE REACTION 5 0.0017
161 INFUSION SITE ERYTHEMA 14 0.0017
162 EAR DISCOMFORT 17 0.0017
163 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 9 0.0017
164 EAR INFECTION 44 0.0017
165 UPPER RESPIRATORY TRACT INFECTION 76 0.0016
166 PRODUCTIVE COUGH 78 0.0016
167 SINUS CONGESTION 22 0.0016
168 TONGUE DISCOLOURATION 7 0.0016
169 BLOOD CREATININE DECREASED 5 0.0016
170 VASODILATATION 4 0.0016
171 POLYMYALGIA RHEUMATICA 5 0.0016
172 RESPIRATORY TRACT CONGESTION 25 0.0016
173 LOWER RESPIRATORY TRACT INFECTION 71 0.0016
174 MIDDLE INSOMNIA 29 0.0016
175 CONCUSSION 12 0.0015
176 DRUG TITRATION ERROR 4 0.0015
177 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
178 DRUG DELIVERY SYSTEM ISSUE 3 0.0015
179 SECRETION DISCHARGE 19 0.0015
180 ANORGASMIA 4 0.0015
181 MIGRAINE WITH AURA 4 0.0015
182 CYSTIC FIBROSIS 8 0.0014
183 MUSCLE CONTRACTIONS INVOLUNTARY 5 0.0014
184 RESPIRATORY TRACT INFECTION 37 0.0014
185 EYE CONTUSION 3 0.0014
186 PHARYNGEAL ERYTHEMA 3 0.0014
187 GLOSSITIS 5 0.0014
188 TENSION HEADACHE 6 0.0014
189 CORONARY ARTERY STENOSIS 7 0.0014
190 HYPERVENTILATION 8 0.0014
191 DRY THROAT 14 0.0014
192 CUTANEOUS VASCULITIS 5 0.0014
193 LIMB MASS 3 0.0014
194 ENDOCARDITIS 7 0.0014
195 CLOSTRIDIUM TEST POSITIVE 3 0.0014
196 MIDDLE EAR EFFUSION 3 0.0014
197 DIVERTICULUM INTESTINAL HAEMORRHAGIC 3 0.0013
198 FULL BLOOD COUNT ABNORMAL 14 0.0013
199 TENDON PAIN 10 0.0013
200 EAR DISORDER 6 0.0013
201 PARANASAL SINUS HYPERSECRETION 5 0.0013
202 EPISTAXIS 98 0.0013
203 SLEEP APNOEA SYNDROME 25 0.0013
204 HEREDITARY ANGIOEDEMA 14 0.0013
205 PHARYNGITIS STREPTOCOCCAL 14 0.0013
206 DYSGEUSIA 96 0.0013
207 LACRIMATION INCREASED 39 0.0013
208 RESPIRATORY RATE DECREASED 4 0.0013
209 MYOPIA 3 0.0013
210 OBSTRUCTION 5 0.0013
211 DYSPNOEA EXERTIONAL 47 0.0012
212 RESPIRATORY DISORDER 37 0.0012
213 MUSCLE DISORDER 10 0.0012
214 PHARYNGEAL SWELLING 12 0.0012
215 RHINORRHOEA 79 0.0012
216 BREATH SOUNDS ABNORMAL 6 0.0012
217 BLOOD IMMUNOGLOBULIN G DECREASED 3 0.0012
218 SUFFOCATION FEELING 3 0.0012
219 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 58 0.0012
220 METABOLIC DISORDER 7 0.0012
221 HERNIA REPAIR 3 0.0012
222 TACHYPHRENIA 4 0.0012
223 ADRENAL INSUFFICIENCY 14 0.0012
224 HYPERSENSITIVITY VASCULITIS 3 0.0011
225 EOSINOPHILIA 20 0.0011
226 DERMATITIS CONTACT 13 0.0011
227 MENISCUS INJURY 7 0.0011
228 ANIMAL BITE 3 0.0011
229 TEMPOROMANDIBULAR JOINT SYNDROME 3 0.0011
230 OROPHARYNGEAL DISCOMFORT 10 0.0011
231 RED BLOOD CELL COUNT INCREASED 3 0.0011
232 NEPHROGENIC ANAEMIA 5 0.0011
233 FEELING DRUNK 8 0.0011
234 IMMUNODEFICIENCY 16 0.0011
235 CEREBRAL THROMBOSIS 3 0.0011
236 SNORING 4 0.0011
237 PARANASAL SINUS DISCOMFORT 4 0.0011
238 LIP PAIN 3 0.0010
239 THYROID MASS 4 0.0010
240 FIBULA FRACTURE 3 0.0010
241 MOUTH SWELLING 6 0.0010
242 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 72 0.0010
243 RENAL CYST 8 0.0010
244 OBESITY 16 0.0010
245 ATYPICAL PNEUMONIA 3 0.0010
246 AGEUSIA 25 0.0010
247 INSURANCE ISSUE 15 0.0010
248 BRONCHITIS 72 0.0010
249 SPINAL STENOSIS 4 0.0010
250 MULTIPLE-DRUG RESISTANCE 3 0.0010
251 INFUSION SITE EXTRAVASATION 6 0.0010
252 INJECTION SITE HYPERSENSITIVITY 3 0.0010
253 SELF-INJURIOUS IDEATION 4 0.0010
254 GASTROENTERITIS VIRAL 17 0.0009
255 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
256 PSEUDOMONAS INFECTION 8 0.0009
257 PAROSMIA 7 0.0009
258 CHEST DISCOMFORT 95 0.0009
259 ANGINA UNSTABLE 6 0.0009
260 SKIN LACERATION 10 0.0009
261 LYMPHOPENIA 13 0.0009
262 PULMONARY FUNCTION TEST DECREASED 4 0.0009
263 INJECTION SITE INFECTION 3 0.0009
264 COUGH 256 0.0009
265 LIGAMENT SPRAIN 9 0.0009
266 NEAR DEATH EXPERIENCE 3 0.0009
267 DEAFNESS UNILATERAL 5 0.0009
268 CHOKING SENSATION 5 0.0009
269 BLOOD PRESSURE ABNORMAL 18 0.0009
270 SKIN INJURY 3 0.0009
271 DENTAL CARIES 10 0.0009
272 CATHETERISATION CARDIAC 4 0.0009
273 FOOT DEFORMITY 10 0.0009
274 VIRAL INFECTION 30 0.0009
275 IRON DEFICIENCY 4 0.0009
276 CANDIDA INFECTION 15 0.0009
277 PHARYNGITIS 11 0.0009
278 SCIATICA 14 0.0009
279 ARTHRITIS 69 0.0009
280 EAR PAIN 17 0.0009
281 PERIPHERAL COLDNESS 12 0.0009
282 THROAT IRRITATION 39 0.0009
283 EXERCISE TOLERANCE DECREASED 5 0.0009
284 BLOOD PRESSURE DIASTOLIC INCREASED 4 0.0009
285 ARTHRITIS INFECTIVE 4 0.0009
286 HUNGER 12 0.0009
287 DEFAECATION URGENCY 6 0.0009
288 EAR PRURITUS 3 0.0009
289 HANGOVER 3 0.0009
290 LUNG TRANSPLANT 3 0.0008
291 NODULE 11 0.0008
292 SINUS HEADACHE 5 0.0008
293 ENDOMETRIOSIS 4 0.0008
294 HEPATITIS CHOLESTATIC 5 0.0008
295 NOCTURIA 10 0.0008
296 ASTHMATIC CRISIS 3 0.0008
297 COELIAC DISEASE 8 0.0008
298 PRODUCT TASTE ABNORMAL 11 0.0008
299 CONJUNCTIVITIS 15 0.0008
300 BLADDER DISORDER 8 0.0008
301 RETCHING 17 0.0008
302 ERYSIPELAS 4 0.0008
303 GASTROOESOPHAGEAL REFLUX DISEASE 64 0.0008
304 AUTOIMMUNE THYROIDITIS 3 0.0008
305 OSTEOPENIA 12 0.0008
306 FACE INJURY 3 0.0008
307 HYPOMAGNESAEMIA 11 0.0008
308 ENTERITIS 5 0.0008
309 FEMORAL NECK FRACTURE 4 0.0008
310 BRONCHOSPASM 11 0.0008
311 APNOEA 6 0.0008
312 RESTLESS LEGS SYNDROME 14 0.0008
313 HERPES SIMPLEX 5 0.0008
314 ORAL INFECTION 3 0.0008
315 END STAGE RENAL DISEASE 14 0.0008
316 SEXUAL DYSFUNCTION 9 0.0008
317 PLATELET COUNT INCREASED 10 0.0008
318 IMPAIRED QUALITY OF LIFE 11 0.0008
319 PRODUCT ODOUR ABNORMAL 8 0.0008
320 ORAL CANDIDIASIS 10 0.0008
321 SCRATCH 8 0.0008
322 IRON DEFICIENCY ANAEMIA 7 0.0008
323 MACULAR DEGENERATION 9 0.0008
324 OESOPHAGEAL CANDIDIASIS 3 0.0008
325 HYPOTHYROIDISM 24 0.0008
326 MENINGITIS 5 0.0007
327 BLEPHARITIS 3 0.0007
328 LACERATION 7 0.0007
329 LOCALISED INFECTION 18 0.0007
330 PRODUCT DELIVERY MECHANISM ISSUE 4 0.0007
331 MIGRAINE 71 0.0007
332 PRODUCT LABEL ISSUE 5 0.0007
333 HYDROCEPHALUS 4 0.0007
334 GOITRE 3 0.0007
335 THYROID FUNCTION TEST ABNORMAL 3 0.0007
336 EXPIRED PRODUCT ADMINISTERED 24 0.0007
337 AUTOIMMUNE DISORDER 7 0.0007
338 HEART RATE ABNORMAL 4 0.0007
339 EXTRASYSTOLES 5 0.0007
340 PRODUCT LEAKAGE 4 0.0007
341 OCULAR DISCOMFORT 8 0.0007
342 MOUTH ULCERATION 15 0.0007
343 DUODENAL ULCER 5 0.0007
344 THROAT TIGHTNESS 19 0.0007
345 SHOULDER OPERATION 3 0.0007
346 SCAB 8 0.0007
347 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
348 NEUTROPENIC SEPSIS 5 0.0007
349 ABNORMAL SENSATION IN EYE 3 0.0007
350 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0007
351 MUSCULOSKELETAL DISCOMFORT 12 0.0007
352 NIGHTMARE 24 0.0007
353 OROPHARYNGEAL PAIN 64 0.0007
354 ANAPHYLACTIC REACTION 38 0.0007
355 EYE PRURITUS 23 0.0007
356 MELANOCYTIC NAEVUS 3 0.0007
357 INTENTIONAL DEVICE MISUSE 3 0.0007
358 LUNG DISORDER 33 0.0007
359 ODYNOPHAGIA 4 0.0007
360 MENINGITIS ASEPTIC 3 0.0007
361 CHOKING 13 0.0007
362 EXOSTOSIS 6 0.0007
363 EYE PAIN 37 0.0007
364 EYE OPERATION 3 0.0007
365 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
366 ANKLE FRACTURE 10 0.0006
367 SCOLIOSIS 4 0.0006
368 ROSACEA 3 0.0006
369 BACTERIAL INFECTION 12 0.0006
370 PERFORMANCE STATUS DECREASED 3 0.0006
371 SWOLLEN TONGUE 20 0.0006
372 ASPIRATION 7 0.0006
373 FURUNCLE 5 0.0006
374 FOREIGN BODY SENSATION IN EYES 4 0.0006
375 THERAPEUTIC RESPONSE UNEXPECTED 28 0.0006
376 PNEUMONIA 202 0.0006
377 ROTATOR CUFF SYNDROME 8 0.0006
378 HEAD DISCOMFORT 11 0.0006
379 ILLNESS 64 0.0006
380 FRUSTRATION TOLERANCE DECREASED 5 0.0006
381 DIZZINESS POSTURAL 6 0.0006
382 PRESYNCOPE 15 0.0006
383 THIRST 11 0.0006
384 DYSPHONIA 36 0.0006
385 VITAMIN D DEFICIENCY 6 0.0006
386 TENDON DISORDER 4 0.0006
387 KIDNEY INFECTION 12 0.0006
388 TINNITUS 28 0.0006
389 EYE DISORDER 20 0.0006
390 INFECTION 86 0.0006
391 DRUG TOLERANCE 3 0.0006
392 COVID-19 PNEUMONIA 7 0.0006
393 DRY MOUTH 48 0.0006
394 LIMB INJURY 16 0.0006
395 ANGIOEDEMA 26 0.0006
396 PHLEBITIS 3 0.0006
397 PHARYNGEAL OEDEMA 9 0.0006
398 WRIST FRACTURE 7 0.0006
399 DRY EYE 29 0.0006
400 RESPIRATION ABNORMAL 4 0.0006
401 DYSPNOEA 328 0.0006
402 BLOOD MAGNESIUM DECREASED 5 0.0006
403 PERIORBITAL OEDEMA 3 0.0006
404 EYE DISCHARGE 6 0.0006
405 DIVERTICULITIS 16 0.0006
406 PYELONEPHRITIS 5 0.0006
407 TENDERNESS 6 0.0006
408 DEAFNESS 15 0.0006
409 MASS 8 0.0006
410 SOMNOLENCE 115 0.0006
411 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
412 POLYARTHRITIS 3 0.0006
413 SPINAL OPERATION 7 0.0006
414 VISION BLURRED 78 0.0006
415 CYSTITIS 18 0.0006
416 OVERWEIGHT 3 0.0006
417 POOR QUALITY SLEEP 12 0.0006
418 GOUT 10 0.0006
419 ERYTHEMA OF EYELID 3 0.0006
420 TONGUE DISORDER 4 0.0006
421 FAECALOMA 3 0.0005
422 MAJOR DEPRESSION 4 0.0005
423 NONSPECIFIC REACTION 3 0.0005
424 INCREASED TENDENCY TO BRUISE 5 0.0005
425 CEREBRAL DISORDER 4 0.0005
426 NERVE INJURY 6 0.0005
427 INFLUENZA 60 0.0005
428 NEURALGIA 13 0.0005
429 TOOTH INFECTION 7 0.0005
430 CHRONIC KIDNEY DISEASE 40 0.0005
431 VERTIGO 32 0.0005
432 SKIN ATROPHY 3 0.0005
433 EYE IRRITATION 30 0.0005
434 PALPITATIONS 61 0.0005
435 DISTURBANCE IN ATTENTION 28 0.0005
436 BLOOD PRESSURE INCREASED 79 0.0005
437 TENDONITIS 8 0.0005
438 RALES 3 0.0005
439 EYELID OEDEMA 6 0.0005
440 LOCAL SWELLING 9 0.0005
441 APHTHOUS ULCER 4 0.0005
442 LIP SWELLING 17 0.0005
443 BODY TEMPERATURE DECREASED 5 0.0005
444 SWELLING FACE 33 0.0005
445 PLATELET COUNT DECREASED 54 0.0005
446 HALLUCINATION, AUDITORY 8 0.0005
447 SYMPTOM RECURRENCE 3 0.0005
448 CARPAL TUNNEL SYNDROME 7 0.0005
449 ECZEMA 26 0.0005
450 SLEEP DISORDER 35 0.0005
451 FIBROMYALGIA 12 0.0005
452 POST PROCEDURAL INFECTION 4 0.0005
453 DECUBITUS ULCER 4 0.0005
454 FEELING HOT 30 0.0005
455 HEART RATE IRREGULAR 11 0.0005
456 PIGMENTATION DISORDER 3 0.0005
457 PARAESTHESIA ORAL 7 0.0005
458 TEMPERATURE INTOLERANCE 5 0.0005
459 HEART RATE INCREASED 48 0.0005
460 COVID-19 85 0.0005
461 EYE SWELLING 18 0.0005
462 POOR VENOUS ACCESS 5 0.0005
463 VENTRICULAR EXTRASYSTOLES 5 0.0005
464 DISORIENTATION 19 0.0005
465 PALLOR 13 0.0005
466 MOOD ALTERED 13 0.0005
467 SENSATION OF FOREIGN BODY 4 0.0005
468 PHOTOPSIA 3 0.0005
469 SCREAMING 3 0.0005
470 FACIAL PARALYSIS 4 0.0005
471 JOINT INJURY 10 0.0005
472 VITAMIN D DECREASED 4 0.0005
473 MYDRIASIS 6 0.0005
474 BODY HEIGHT DECREASED 5 0.0005
475 HAEMATURIA 16 0.0005
476 HAEMOGLOBIN ABNORMAL 3 0.0005
477 HAEMOPTYSIS 13 0.0005
478 NIGHT SWEATS 15 0.0005
479 MUSCLE STRAIN 4 0.0005
480 ORAL HERPES 9 0.0005
481 OESOPHAGITIS 5 0.0005
482 CONDITION AGGRAVATED 139 0.0005
483 SOMNAMBULISM 3 0.0005
484 CELLULITIS 23 0.0005
485 GASTROINTESTINAL PAIN 5 0.0005
486 MUSCULOSKELETAL CHEST PAIN 7 0.0005
487 UPPER LIMB FRACTURE 9 0.0005
488 RENAL DISORDER 21 0.0005
489 LUNG INFECTION 7 0.0005
490 ANXIETY 128 0.0004
491 SKIN MASS 3 0.0004
492 POST-TRAUMATIC STRESS DISORDER 3 0.0004
493 BREAST MASS 3 0.0004
494 POSTOPERATIVE WOUND INFECTION 3 0.0004
495 ARRHYTHMIA 21 0.0004
496 HEADACHE 278 0.0004
497 WHITE BLOOD CELL COUNT DECREASED 48 0.0004
498 HYPERSENSITIVITY 82 0.0004
499 LIP DRY 4 0.0004
500 IMPAIRED DRIVING ABILITY 5 0.0004
501 PANIC ATTACK 16 0.0004
502 RETINAL DETACHMENT 4 0.0004
503 DEPRESSED MOOD 23 0.0004
504 LETHARGY 25 0.0004
505 LYMPHOEDEMA 3 0.0004
506 NERVE COMPRESSION 4 0.0004
507 NASOPHARYNGITIS 79 0.0004
508 ERECTILE DYSFUNCTION 11 0.0004
509 TACHYCARDIA 38 0.0004
510 KNEE ARTHROPLASTY 9 0.0004
511 SKIN REACTION 6 0.0004
512 PAPULE 3 0.0004
513 DIPLOPIA 11 0.0004
514 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
515 THERMAL BURN 3 0.0004
516 MUSCULAR WEAKNESS 48 0.0004
517 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
518 OCULAR HYPERAEMIA 20 0.0004
519 BLOOD IRON DECREASED 5 0.0004
520 PRODUCT PACKAGING ISSUE 4 0.0004
521 FUNGAL INFECTION 14 0.0004
522 JOINT STIFFNESS 11 0.0004
523 CHILLS 49 0.0004
524 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
525 SWELLING 39 0.0004
526 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 75 0.0004
527 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
528 SUICIDAL IDEATION 38 0.0004
529 NEPHROLITHIASIS 19 0.0004
530 PRODUCT QUALITY ISSUE 56 0.0004
531 URTICARIA 69 0.0004
532 ACUTE KIDNEY INJURY 63 0.0004
533 PRODUCT USE ISSUE 77 0.0004
534 SCAR 7 0.0004
535 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
536 DYSPEPSIA 40 0.0004
537 BLOOD PRESSURE DECREASED 27 0.0004
538 ARTHROPOD BITE 3 0.0004
539 DISABILITY 8 0.0004
540 URINARY TRACT INFECTION 69 0.0004
541 GLOSSODYNIA 9 0.0004
542 ABDOMINAL DISCOMFORT 67 0.0004
543 CHROMATURIA 9 0.0004
544 HYPOAESTHESIA ORAL 6 0.0004
545 COLD SWEAT 7 0.0004
546 THERAPEUTIC RESPONSE DECREASED 24 0.0004
547 VAGINAL DISCHARGE 4 0.0004
548 SUBARACHNOID HAEMORRHAGE 4 0.0004
549 MOTOR DYSFUNCTION 4 0.0004
550 INTRAOCULAR PRESSURE INCREASED 5 0.0004
551 VISUAL IMPAIRMENT 48 0.0004
552 LEUKOCYTOSIS 7 0.0004
553 CATARACT 23 0.0004
554 BASAL CELL CARCINOMA 6 0.0004
555 WEIGHT FLUCTUATION 4 0.0004
556 JOINT DISLOCATION 4 0.0004
557 BLOOD ALBUMIN DECREASED 3 0.0004
558 GINGIVAL PAIN 3 0.0004
559 INFLUENZA LIKE ILLNESS 31 0.0004
560 MYALGIA 64 0.0004
561 THINKING ABNORMAL 7 0.0004
562 OBSESSIVE-COMPULSIVE DISORDER 3 0.0004
563 MALIGNANT MELANOMA 5 0.0004
564 JOINT SWELLING 45 0.0004
565 QUALITY OF LIFE DECREASED 5 0.0004
566 DECREASED ACTIVITY 4 0.0004
567 BURNING SENSATION 26 0.0004
568 BACK DISORDER 6 0.0004
569 FATIGUE 287 0.0004
570 PRODUCT DOSE OMISSION 24 0.0004
571 PULMONARY THROMBOSIS 4 0.0004
572 ABNORMAL FAECES 3 0.0004
573 HICCUPS 3 0.0004
574 WOUND INFECTION 4 0.0004
575 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
576 DIZZINESS 180 0.0004
577 ORAL DISCOMFORT 5 0.0004
578 ORAL PAIN 8 0.0004
579 PERICARDITIS 6 0.0004
580 EYE INFECTION 4 0.0004
581 CONTUSION 34 0.0004
582 PAIN IN JAW 10 0.0004
583 CIRCULATORY COLLAPSE 6 0.0004
584 PRODUCT AVAILABILITY ISSUE 8 0.0004
585 INTERNAL HAEMORRHAGE 4 0.0003
586 CARDIAC OPERATION 3 0.0003
587 HYPERSOMNIA 10 0.0003
588 HEAD INJURY 11 0.0003
589 HYPOAESTHESIA 52 0.0003
590 SKIN SWELLING 3 0.0003
591 INSOMNIA 92 0.0003
592 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
593 PSORIATIC ARTHROPATHY 14 0.0003
594 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
595 NERVOUSNESS 18 0.0003
596 VASCULITIS 4 0.0003
597 ANHEDONIA 9 0.0003
598 HEART RATE DECREASED 12 0.0003
599 DERMATITIS ATOPIC 18 0.0003
600 GRIP STRENGTH DECREASED 3 0.0003
601 RIB FRACTURE 7 0.0003
602 NECK PAIN 19 0.0003
603 CARDIOMYOPATHY 5 0.0003
604 OXYGEN SATURATION DECREASED 19 0.0003
605 RESPIRATORY RATE INCREASED 3 0.0003
606 URINARY INCONTINENCE 10 0.0003
607 MALAISE 148 0.0003
608 PARAESTHESIA 53 0.0003
609 IMPAIRED HEALING 11 0.0003
610 HAEMORRHAGE 35 0.0003
611 GASTROINTESTINAL INFECTION 3 0.0003
612 DERMATITIS 7 0.0003
613 FEELING ABNORMAL 80 0.0003
614 ANAL INCONTINENCE 3 0.0003
615 WEIGHT DECREASED 93 0.0003
616 RASH PRURITIC 18 0.0003
617 OEDEMA 18 0.0003
618 TOOTHACHE 6 0.0003
619 HERPES ZOSTER 19 0.0003
620 UNEVALUABLE EVENT 25 0.0003
621 DEPRESSION 75 0.0003
622 BONE DISORDER 6 0.0003
623 GAIT INABILITY 11 0.0003
624 DEVICE FAILURE 5 0.0003
625 RESTLESSNESS 12 0.0003
626 DYSPHAGIA 31 0.0003
627 SURGERY 19 0.0003
628 PRURITUS GENERALISED 7 0.0003
629 PRODUCT USE IN UNAPPROVED INDICATION 80 0.0003
630 ERYTHEMA MULTIFORME 3 0.0003
631 PRURITUS 123 0.0003
632 FLANK PAIN 3 0.0003
633 BRAIN FOG 5 0.0003
634 SQUAMOUS CELL CARCINOMA 3 0.0003
635 FALL 106 0.0003
636 ATRIAL FIBRILLATION 31 0.0003
637 OSTEOPOROSIS 13 0.0003
638 INTENTIONAL DOSE OMISSION 9 0.0003
639 FEELING JITTERY 6 0.0003
640 RASH MACULAR 11 0.0003
641 AFFECT LABILITY 3 0.0003
642 LYMPHADENOPATHY 11 0.0003
643 MUSCLE SPASMS 57 0.0003
644 HYPERHIDROSIS 40 0.0003
645 ATELECTASIS 3 0.0003
646 INFLAMMATION 16 0.0003
647 SKIN ULCER 8 0.0003
648 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
649 PRODUCT DOSE OMISSION ISSUE 90 0.0003
650 THERAPY CHANGE 3 0.0003
651 NAUSEA 241 0.0003
652 INCORRECT PRODUCT STORAGE 4 0.0003
653 IMMUNE SYSTEM DISORDER 4 0.0003
654 ANKYLOSING SPONDYLITIS 4 0.0003
655 PYREXIA 105 0.0003
656 PULMONARY CONGESTION 4 0.0003
657 STAPHYLOCOCCAL INFECTION 10 0.0003
658 PERICARDIAL EFFUSION 7 0.0003
659 ARTHRALGIA 125 0.0003
660 SYNCOPE 30 0.0003
661 EYE HAEMORRHAGE 4 0.0003
662 URINARY RETENTION 10 0.0003
663 WEIGHT INCREASED 67 0.0003
664 HAIR TEXTURE ABNORMAL 4 0.0003
665 MEMORY IMPAIRMENT 41 0.0003
666 CORONARY ARTERY DISEASE 9 0.0003
667 PAIN OF SKIN 8 0.0003
668 FEEDING DISORDER 6 0.0003
669 DISCOMFORT 18 0.0003
670 TOOTH ABSCESS 3 0.0003
671 TACHYPNOEA 4 0.0003
672 EUPHORIC MOOD 3 0.0003
673 PERIPHERAL SWELLING 45 0.0003
674 HELICOBACTER INFECTION 3 0.0003
675 PAIN IN EXTREMITY 85 0.0003
676 DEVICE DEFECTIVE 5 0.0003
677 ERYTHEMA 59 0.0003
678 COORDINATION ABNORMAL 4 0.0003
679 CHEST PAIN 53 0.0003
680 INJECTION SITE DISCOMFORT 3 0.0003
681 HALLUCINATION, VISUAL 6 0.0003
682 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 57 0.0003
683 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 20 0.0003
684 CONFUSIONAL STATE 45 0.0003
685 LACTIC ACIDOSIS 9 0.0003
686 TREMOR 46 0.0003
687 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
688 INJECTION SITE BRUISING 22 0.0003
689 FLUID RETENTION 14 0.0003
690 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
691 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
692 RASH ERYTHEMATOUS 13 0.0003
693 ANAPHYLACTIC SHOCK 7 0.0003
694 BLOOD GLUCOSE ABNORMAL 5 0.0003
695 RASH MACULO-PAPULAR 6 0.0003
696 DRUG INTOLERANCE 26 0.0003
697 AGRANULOCYTOSIS 5 0.0003
698 PANCYTOPENIA 15 0.0003
699 SKIN INFECTION 3 0.0003
700 NEPHROPATHY TOXIC 3 0.0003
701 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
702 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
703 BLOOD POTASSIUM DECREASED 8 0.0003
704 ECONOMIC PROBLEM 4 0.0003
705 MICTURITION URGENCY 3 0.0003
706 INTENTIONAL PRODUCT USE ISSUE 23 0.0003
707 OEDEMA PERIPHERAL 32 0.0003
708 DRY SKIN 35 0.0003
709 DRUG DISPENSING ERROR 4 0.0003
710 NEOPLASM 3 0.0003
711 DRUG PRESCRIBING ERROR 5 0.0003
712 LOWER LIMB FRACTURE 5 0.0003
713 DELIRIUM 9 0.0003
714 ABDOMINAL DISTENSION 27 0.0003
715 ABDOMINAL PAIN 60 0.0003
716 BLOOD CHOLESTEROL INCREASED 12 0.0003
717 SKIN FISSURES 5 0.0003
718 HYPOACUSIS 11 0.0003
719 BONE DENSITY DECREASED 8 0.0003
720 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 14 0.0003
721 PRODUCT USE COMPLAINT 4 0.0003
722 ARTHROPATHY 14 0.0003
723 HYPERLIPIDAEMIA 3 0.0003
724 RENAL IMPAIRMENT 21 0.0002
725 INTERSTITIAL LUNG DISEASE 12 0.0002
726 PRODUCT ADMINISTRATION ERROR 5 0.0002
727 BURSITIS 3 0.0002
728 EXTRA DOSE ADMINISTERED 10 0.0002
729 FLUSHING 25 0.0002
730 HYPERTENSION 52 0.0002
731 DEVICE ISSUE 22 0.0002
732 DIARRHOEA 158 0.0002
733 ASTHENIA 92 0.0002
734 CHOLELITHIASIS 8 0.0002
735 TENDON RUPTURE 3 0.0002
736 HYPERCALCAEMIA 3 0.0002
737 GENERALISED OEDEMA 3 0.0002
738 PHOTOSENSITIVITY REACTION 4 0.0002
739 INFUSION RELATED REACTION 16 0.0002
740 EXPOSURE DURING PREGNANCY 15 0.0002
741 HAIR COLOUR CHANGES 3 0.0002
742 NEEDLE ISSUE 7 0.0002
743 BONE PAIN 14 0.0002
744 BLOOD UREA INCREASED 4 0.0002
745 COLITIS 9 0.0002
746 FACE OEDEMA 4 0.0002
747 ANGER 8 0.0002
748 DIABETES MELLITUS 18 0.0002
749 DRUG INEFFECTIVE 311 0.0002
750 OSTEOARTHRITIS 10 0.0002
751 RENAL INJURY 7 0.0002
752 COGNITIVE DISORDER 11 0.0002
753 GASTROINTESTINAL DISORDER 21 0.0002
754 CONSTIPATION 51 0.0002
755 IRRITABLE BOWEL SYNDROME 5 0.0002
756 LIVER FUNCTION TEST INCREASED 5 0.0002
757 SKIN CANCER 5 0.0002
758 ILL-DEFINED DISORDER 14 0.0002
759 MENTAL DISORDER 10 0.0002
760 PRODUCT PRESCRIBING ISSUE 5 0.0002
761 HYPOTENSION 46 0.0002
762 GASTRITIS 6 0.0002
763 HYPOXIA 8 0.0002
764 SARS-COV-2 TEST POSITIVE 3 0.0002
765 LYMPHOCYTE COUNT DECREASED 4 0.0002
766 LIMB DISCOMFORT 7 0.0002
767 PRODUCT SUBSTITUTION ISSUE 13 0.0002
768 HALLUCINATION 17 0.0002
769 PAIN 138 0.0002
770 BREAST CANCER FEMALE 6 0.0002
771 DRUG DOSE OMISSION 37 0.0002
772 BACK PAIN 52 0.0002
773 PULMONARY OEDEMA 10 0.0002
774 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
775 THERAPY NON-RESPONDER 10 0.0002
776 INJECTION SITE SWELLING 17 0.0002
777 BLINDNESS 9 0.0002
778 DRUG EFFECT INCOMPLETE 8 0.0002
779 HEPATIC ENZYME INCREASED 15 0.0002
780 BALANCE DISORDER 19 0.0002
781 VOMITING 103 0.0002
782 MUSCLE TWITCHING 5 0.0002
783 IRRITABILITY 13 0.0002
784 ALOPECIA 42 0.0002
785 BLISTER 12 0.0002
786 HYPONATRAEMIA 12 0.0002
787 BLINDNESS UNILATERAL 3 0.0002
788 PHOTOPHOBIA 4 0.0002
789 BLOOD SODIUM DECREASED 4 0.0002
790 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
791 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
792 FEBRILE NEUTROPENIA 14 0.0002
793 LOSS OF CONSCIOUSNESS 27 0.0002
794 BLOOD URINE PRESENT 4 0.0002
795 INCORRECT DOSE ADMINISTERED 48 0.0002
796 DISEASE RECURRENCE 10 0.0002
797 SPEECH DISORDER 11 0.0002
798 PRODUCT PRESCRIBING ERROR 5 0.0002
799 THERAPY INTERRUPTED 15 0.0002
800 RED BLOOD CELL COUNT DECREASED 6 0.0002
801 PARALYSIS 3 0.0002
802 PULMONARY FIBROSIS 4 0.0002
803 POST PROCEDURAL COMPLICATION 4 0.0002
804 ACUTE RESPIRATORY FAILURE 4 0.0002
805 HERNIA 4 0.0002
806 ERUCTATION 4 0.0002
807 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
808 GASTROENTERITIS 3 0.0002
809 HAEMORRHOIDS 4 0.0002
810 GASTRIC DISORDER 7 0.0002
811 SKIN HAEMORRHAGE 3 0.0002
812 OFF LABEL USE 176 0.0002
813 ABORTION SPONTANEOUS 8 0.0002
814 THROMBOSIS 16 0.0002
815 APHASIA 6 0.0002
816 GAIT DISTURBANCE 38 0.0002
817 EMOTIONAL DISTRESS 24 0.0002
818 BODY TEMPERATURE INCREASED 4 0.0002
819 HIP ARTHROPLASTY 3 0.0002
820 RENAL FAILURE 26 0.0002
821 DEVICE RELATED INFECTION 3 0.0002
822 THYROID DISORDER 3 0.0002
823 INJECTION SITE WARMTH 4 0.0002
824 LYMPHOMA 3 0.0002
825 FLATULENCE 11 0.0002
826 INJECTION SITE ERYTHEMA 24 0.0002
827 HAEMATOMA 5 0.0002
828 EXPOSURE VIA SKIN CONTACT 5 0.0002
829 POLLAKIURIA 8 0.0002
830 GASTROINTESTINAL HAEMORRHAGE 16 0.0002
831 SEIZURE 22 0.0002
832 RASH 83 0.0002
833 DYSURIA 7 0.0002
834 DECREASED APPETITE 44 0.0002
835 INJECTION SITE MASS 7 0.0002
836 PNEUMOTHORAX 3 0.0002
837 NO ADVERSE EVENT 34 0.0002
838 DEHYDRATION 25 0.0002
839 MOVEMENT DISORDER 6 0.0002
840 MUSCLE TIGHTNESS 3 0.0002
841 FREQUENT BOWEL MOVEMENTS 5 0.0002
842 BLOOD POTASSIUM INCREASED 3 0.0002
843 MELAENA 4 0.0002
844 RESPIRATORY DISTRESS 5 0.0002
845 ABNORMAL DREAMS 5 0.0002
846 INJECTION SITE PAIN 55 0.0002
847 RASH PAPULAR 4 0.0002
848 HEMIPARESIS 3 0.0002
849 PSORIASIS 23 0.0002
850 HOSPITALISATION 27 0.0002
851 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
852 ABDOMINAL PAIN UPPER 36 0.0002
853 SKIN IRRITATION 8 0.0002
854 PARANOIA 3 0.0002
855 ORTHOSTATIC HYPOTENSION 3 0.0002
856 MUSCULOSKELETAL PAIN 9 0.0002
857 INTENTIONAL PRODUCT MISUSE 15 0.0002
858 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 8 0.0002
859 DEVICE MALFUNCTION 12 0.0002
860 BRADYCARDIA 9 0.0002
861 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
862 DRUG ERUPTION 3 0.0002
863 GALLBLADDER DISORDER 3 0.0002
864 ROAD TRAFFIC ACCIDENT 7 0.0002
865 MOBILITY DECREASED 12 0.0002
866 BLOOD PRESSURE FLUCTUATION 4 0.0002
867 BLOOD GLUCOSE DECREASED 8 0.0002
868 SYNOVITIS 3 0.0002
869 PELVIC PAIN 3 0.0002
870 CRYING 6 0.0002
871 PLEURAL EFFUSION 10 0.0002
872 INJECTION SITE URTICARIA 4 0.0002
873 LIVER INJURY 4 0.0002
874 SEPSIS 18 0.0002
875 DISEASE PROGRESSION 19 0.0002
876 PNEUMONIA ASPIRATION 4 0.0002
877 LEUKOPENIA 8 0.0002
878 DYSARTHRIA 6 0.0002
879 HOT FLUSH 12 0.0002
880 FRACTURE 3 0.0002
881 ACNE 12 0.0002
882 NEUROPATHY PERIPHERAL 15 0.0002
883 INCREASED APPETITE 3 0.0002
884 GLAUCOMA 3 0.0002
885 RASH GENERALISED 4 0.0002
886 APPLICATION SITE ERYTHEMA 4 0.0002
887 HYPOKALAEMIA 7 0.0002
888 HAEMATOCRIT DECREASED 3 0.0002
889 VISUAL ACUITY REDUCED 5 0.0002
890 SKIN DISORDER 5 0.0001
891 SPINAL FRACTURE 3 0.0001
892 CYTOKINE RELEASE SYNDROME 3 0.0001
893 INJECTION SITE PRURITUS 10 0.0001
894 FULL BLOOD COUNT DECREASED 3 0.0001
895 INTENTIONAL SELF-INJURY 3 0.0001
896 TYPE 2 DIABETES MELLITUS 5 0.0001
897 DRUG EFFECT DECREASED 8 0.0001
898 STOMATITIS 9 0.0001
899 MUSCULOSKELETAL STIFFNESS 13 0.0001
900 MULTIPLE SCLEROSIS 7 0.0001
901 TREATMENT NONCOMPLIANCE 8 0.0001
902 FEELING COLD 4 0.0001
903 SKIN BURNING SENSATION 10 0.0001
904 DRUG INTERACTION 22 0.0001
905 DEVICE LEAKAGE 6 0.0001
906 HYPERGLYCAEMIA 5 0.0001
907 DYSSTASIA 4 0.0001
908 PROSTATE CANCER 11 0.0001
909 ACCIDENTAL OVERDOSE 5 0.0001
910 THERAPY CESSATION 7 0.0001
911 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
912 TRANSAMINASES INCREASED 3 0.0001
913 TOOTH DISORDER 3 0.0001
914 RHEUMATOID ARTHRITIS 15 0.0001
915 SKIN DISCOLOURATION 6 0.0001
916 INJECTION SITE RASH 4 0.0001
917 FEMUR FRACTURE 4 0.0001
918 NERVOUS SYSTEM DISORDER 4 0.0001
919 HAEMATOCHEZIA 7 0.0001
920 HAEMOGLOBIN DECREASED 13 0.0001
921 PULMONARY EMBOLISM 12 0.0001
922 CARDIAC FAILURE CONGESTIVE 10 0.0001
923 HYPOGLYCAEMIA 6 0.0001
924 AMNESIA 8 0.0001
925 CEREBRAL INFARCTION 3 0.0001
926 AGITATION 9 0.0001
927 LUNG NEOPLASM MALIGNANT 5 0.0001
928 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
929 AGGRESSION 6 0.0001
930 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
931 PRODUCT COMPLAINT 3 0.0001
932 SEDATION 3 0.0001
933 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
934 INJURY 8 0.0001
935 PANCREATITIS 6 0.0001
936 LIVER DISORDER 5 0.0001
937 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
938 INJECTION SITE HAEMORRHAGE 9 0.0001
939 ADVERSE DRUG REACTION 10 0.0001
940 BLOOD BILIRUBIN INCREASED 3 0.0001
941 C-REACTIVE PROTEIN INCREASED 4 0.0001
942 UNDERDOSE 8 0.0001
943 SKIN LESION 3 0.0001
944 BREAST CANCER 10 0.0001
945 CARDIAC DISORDER 10 0.0001
946 SKIN EXFOLIATION 9 0.0001
947 BLOOD GLUCOSE INCREASED 20 0.0001
948 ANGINA PECTORIS 3 0.0001
949 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
950 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
951 MULTIPLE SCLEROSIS RELAPSE 7 0.0001
952 ASCITES 3 0.0001
953 INJECTION SITE REACTION 7 0.0001
954 LABORATORY TEST ABNORMAL 3 0.0001
955 MATERNAL EXPOSURE DURING PREGNANCY 9 0.0001
956 ABNORMAL BEHAVIOUR 4 0.0001
957 CEREBROVASCULAR ACCIDENT 17 0.0001
958 EMOTIONAL DISORDER 3 0.0001
959 ANAEMIA 18 0.0001
960 MOOD SWINGS 3 0.0001
961 HIP FRACTURE 3 0.0001
962 RECTAL HAEMORRHAGE 4 0.0001
963 DEEP VEIN THROMBOSIS 6 0.0001
964 OSTEONECROSIS 3 0.0001
965 NEOPLASM MALIGNANT 6 0.0001
966 CARDIAC FAILURE 7 0.0001
967 GENERAL PHYSICAL HEALTH DETERIORATION 10 0.0001
968 RESPIRATORY FAILURE 6 0.0001
969 INTESTINAL OBSTRUCTION 3 0.0001
970 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
971 DEVICE BREAKAGE 3 0.0001
972 NEUTROPENIA 10 0.0001
973 DEVICE DISLOCATION 3 0.0001
974 SEPTIC SHOCK 3 0.0001
975 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
976 MYOCARDIAL INFARCTION 10 0.0001
977 MEDICATION ERROR 3 0.0001
978 THROMBOCYTOPENIA 6 0.0001
979 DRUG DOSE OMISSION BY DEVICE 4 0.0001
980 DEVICE EXPULSION 3 0.0000
981 BLOOD CREATININE INCREASED 3 0.0000
982 PRODUCT STORAGE ERROR 4 0.0000
983 DEVICE DIFFICULT TO USE 3 0.0000
984 OVERDOSE 9 0.0000
985 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
986 DRUG ABUSE 3 0.0000
987 DRUG WITHDRAWAL SYNDROME 3 0.0000
988 DEATH 29 0.0000
989 MALIGNANT NEOPLASM PROGRESSION 3 0.0000